Immunotherapy and radiotherapy in metastatic uveal melanoma: Results from a single institute study

被引:0
|
作者
Guan, Jian
Teh, Bin S.
Schefler, Amy
Bernicker, Eric
机构
[1] Houston Methodist Canc Ctr, Houston, TX USA
[2] Houston Methodist Hosp, Dept Radiat Oncol, Houston, TX USA
[3] Retina Consultants Texas, Bellaire, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21507
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients
    Grynberg, Shirly
    Stoff, Ronen
    Asher, Nethanel
    Shapira-Frommer, Ronnie
    Schachter, Jacob
    Haisraely, Ory
    Lawrence, Yaacov
    Ben-Betzalel, Guy
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [2] Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy
    Orloff, Marlana
    OCULAR ONCOLOGY AND PATHOLOGY, 2021, 7 (03) : 168 - 176
  • [3] Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study
    Pelster, Meredith S.
    Gruschkus, Stephen K.
    Bassett, Roland
    Gombos, Dan S.
    Shephard, Michael
    Posada, Liberty
    Glover, Maura S.
    Simien, Rinata
    Diab, Adi
    Hwu, Patrick
    Carter, Brett W.
    Patel, Sapna P.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06) : 599 - +
  • [4] Single-institute, retrospective study of metastatic uveal melanoma in the immune check point inhibitor era
    Kazuhiro, S.
    Sugiyama, K.
    Nozawa, K.
    Funahashi, Y.
    Kogure, Y.
    Kitagawa, C.
    Ichihara, S.
    Nishimura, R.
    Kubota, T.
    Saka, H.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] Efficacy of immunotherapy in patients with metastatic mucosal or uveal melanoma
    Mignard, C.
    Deschamps-Huvier, A.
    Duval-Modeste, A-B.
    Dutriaux, C.
    Khammari, A.
    Avril, M-F.
    Mortier, L.
    Lesimple, T.
    Gaudy-Marqueste, C.
    Lesage, C.
    Machet, L.
    Aubin, F.
    Meyer, N.
    Benhard, N. Beneton
    Jeudy, G.
    Montaudie, H.
    Arnault, J-P.
    Leccia, M-T.
    Joly, P.
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma
    Gezgin, Gulcin
    Luk, Sietse J.
    Cao, Jinfeng
    Dogrusoz, Mehmet
    van der Steen, Dirk M.
    Hagedoorn, Renate S.
    Krijgsman, Danielle
    van der Velden, Pieter A.
    Field, Matthew G.
    Luyten, Gregorius P. M.
    Szuhai, Karoly
    Harbour, J. William
    Jordanova, Ekaterina S.
    Heemskerk, Mirjam H. M.
    Jager, Martine J.
    JAMA OPHTHALMOLOGY, 2017, 135 (06) : 541 - 549
  • [7] A Rare Case of Metastatic Uveal Melanoma Responding to Immunotherapy
    Fadel, Celine A.
    Kanakamedala, Swathi
    Danak, Shivang U.
    Johnson, Andrew T.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [8] Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
    Mignard, Claire
    Huvier, Aurelie Deschamps
    Gillibert, Andre
    Modeste, Anne Benedicte Duval
    Dutriaux, Caroline
    Khammari, Amir
    Avril, Marie-Francoise
    Kramkimel, Nora
    Mortier, Laurent
    Marcant, Pierre
    Lesimple, Thierry
    Gaudy-Marqueste, Caroline
    Lesage, Candice
    Machet, Laurent
    Aubin, Francois
    Meyer, Nicolas
    Beneton, Nathalie
    Jeudy, Geraldine
    Montaudie, Henri
    Arnault, Jean-Philippe
    Visseaux, Laetitia
    Trabelsi, Sabiha
    Amini-Adle, Mona
    Maubec, Eve
    Le Corre, Yannick
    Lipsker, Dan
    Wierzbicka-Hainaut, Ewa
    Litrowski, Noemie
    Stefan, Andreea
    Brunet-Possenti, Florence
    Leccia, Marie-Therese
    Joly, Pascal
    JOURNAL OF ONCOLOGY, 2018, 2018
  • [9] Dendritic cell based immunotherapy in metastatic uveal melanoma
    Nesselhut, Jan
    Marx, Dagmar
    Chang, Raymond Y.
    Nesselhut, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Osteopontin as a serologic marker for metastatic uveal melanoma:: Results of a pilot study
    Reiniger, Ingrid Wanke
    Wolf, Armin
    Welge-Luessen, Ulrich
    Mueller, Arthur Josef
    Kampik, Anselm
    Schaller, Ulrich Christoph
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (04) : 705 - 707